QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 280 filers reported holding QIAGEN NV in Q2 2023. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $3,444,750 | +1195.0% | 75,000 | +1465.8% | 0.02% | +1400.0% |
Q4 2021 | $266,000 | -88.0% | 4,790 | -88.9% | 0.00% | -90.0% |
Q3 2021 | $2,223,000 | -14.8% | 43,007 | -20.3% | 0.01% | -16.7% |
Q2 2021 | $2,609,000 | -75.2% | 53,936 | -75.0% | 0.01% | -75.0% |
Q1 2021 | $10,509,000 | +33.7% | 215,826 | +45.1% | 0.05% | +41.2% |
Q4 2020 | $7,863,000 | +2240.2% | 148,786 | +1697.8% | 0.03% | +1600.0% |
Q2 2019 | $336,000 | -94.1% | 8,276 | -94.1% | 0.00% | -93.8% |
Q1 2019 | $5,730,000 | +14.9% | 140,859 | -2.7% | 0.03% | +3.2% |
Q4 2018 | $4,987,000 | -46.3% | 144,761 | -40.9% | 0.03% | -36.7% |
Q3 2018 | $9,281,000 | +3.1% | 245,009 | -1.5% | 0.05% | -2.0% |
Q2 2018 | $8,998,000 | +10.7% | 248,829 | -1.1% | 0.05% | +8.7% |
Q1 2018 | $8,129,000 | -22.0% | 251,609 | -25.3% | 0.05% | -19.3% |
Q4 2017 | $10,423,000 | -47.8% | 336,985 | -46.8% | 0.06% | -50.4% |
Q3 2017 | $19,949,000 | +9.4% | 633,300 | +16.5% | 0.12% | +0.9% |
Q2 2017 | $18,234,000 | – | 543,809 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SYCOMORE ASSET MANAGEMENT | 2,368,913 | $86,182,000 | 40.56% |
Hardman Johnston Global Advisors LLC | 4,407,084 | $151,824,000 | 7.86% |
Tikvah Management LLC | 442,942 | $15,259,000 | 5.41% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 2,594,057 | $88,155,000 | 3.09% |
Opus Point Partners Management, LLC | 31,463 | $1,084,000 | 2.39% |
SECTOR GAMMA AS | 407,406 | $14,035,000 | 2.36% |
SANDLER CAPITAL MANAGEMENT | 804,049 | $27,699,000 | 2.35% |
Sivik Global Healthcare LLC | 110,800 | $3,817,000 | 2.06% |
Acorn Advisory Capital L.P. | 9,800 | $338,000 | 1.21% |
Eversept Partners, LP | 55,300 | $1,905,085 | 1.03% |